| Name |
Streptantibioticus cattleyicolor Madhaiyan et al. 2022 |
|
| Strain designation | NRRL 8057 |
|
| Other collections | ATCC 35852; CCRC 13439; DSM 46488; IFO 14057; IMET 43729; JCM 4925; KCC S-0925; Merck and Co. Inc. MA-4297; NCIMB 11928 |
|
| Access in situ (sampling data) |
Source: Soil
Country of access: United States
Locality, State of access: New Jersey
Date of access: Before 05-09-1978 |
|
| History | CECT, 1987 < NRRL (Streptomyces cattleya) < Merck and Co. Inc. |
|
| Growth conditions | Culture media: 56/118
Growth temperature (in °C): 30
Incubation time: 7d
Atmospheric needs: aerobic
Cultivation conditions for CECT strains |
|
| Metabolites production | fluorothreonine, fluoroacetic acid, beta-ethynylserine |
|
| Restrictions | Risk group: 1
CECT MTA |
|
| Genetic data | G+C mol%: 73.0
16S rRNA sequence: FQ859185
Complete genome sequence: GCA_000240165 |
|
| Patents | US patents 3950357, 4006060, 4168268, 4198338, 4282322, 4304867 production of thienamycin; US patent 4335212, production of 8-epi-thienamycin; US patent 4247640, production of northienamycin |
|
| Delivery | | Freeze-dried culture | | Acticult® 3R | | Active culture rate A | | Genomic DNA |
Tarifas de presentaciones |
|
|
| La CECT sigue estándares de calidad para garantizar la viabilidad, pureza y autenticidad de las cepas que conserva. La información mostrada en esta ficha procede de diversas fuentes. Algunas de las propiedades no han sido necesariamente contrastadas por la CECT |